Page 1
Page 1
Management of Thyroid Cancer and Related Nodular Disease
Management of Thyroid Cancer and Related Nodular Disease is an authoritative, readable book covering all aspects of thyroid cancer. The text is extensively referenced and includes personal experience of 35 years working with patients with thyroid disorders, including thyroid nodules and thyroid cancer. The chapters are supplemented with many illustrations including pathology, thyroid and whole-body scans, ultrasounds and other nuclear medicine and radiological studies. Important questions that patients may ask their physicians are highlighted, indicating the topics the physician should cover.
70 Years of Levothyroxine
Presents the history, pharmacokinetics and pharmacodynamics of levothyroxine, discussing its role in the thyroid pathophysiology of patients of various ages and during pregnancy. It also describes the influence of levothyroxine on heart, bone and in cancer. When it was first synthesized in 1949, levothyroxine represented a significant advance in the treatment of hypothyroidism, providing a safe and effective treatment option for millions of hypothyroid patients around the globe. This synthetic form of thyroxine is now one of the most prescribed drugs in the world. Levothyroxine was first introduced by Merck KGaA,Darmstadt, Germany, in 1972, and since then the company has remained actively engaged in research on this mainstay of hypothyroidism treatment.
